Exane Derivatives’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,659
| Closed | -$336K | – | 917 |
|
|
2022
Q1 | $336K | Buy |
+4,659
| New | +$336K | 0.09% | 235 |
|
|
2021
Q4 | – | Sell |
-4,769
| Closed | -$605K | – | 955 |
|
|
2021
Q3 | $605K | Buy |
4,769
+413
| +9% | +$52.4K | 0.15% | 146 |
|
|
2021
Q2 | $672K | Buy |
4,356
+2,617
| +150% | +$404K | 0.15% | 131 |
|
|
2021
Q1 | $316K | Sell |
1,739
-1,824
| -51% | -$331K | 0.09% | 203 |
|
|
2020
Q4 | $712K | Buy |
3,563
+1,564
| +78% | +$313K | 0.21% | 104 |
|
|
2020
Q3 | $438K | Buy |
+1,999
| New | +$438K | 0.13% | 134 |
|